A defined-risks approach to the regulatory assessment of the use of neoplastic cells as substrates for viral vaccine manufacture
Dev Biol (Basel)
.
2001:106:513-35.
Authors
A M Lewis Jr
1
,
P Krause
,
K Peden
Affiliation
1
Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food And Drug Administration, Bethesda, MD 20892, USA.
PMID:
11761266
No abstract available
MeSH terms
Drug Industry / legislation & jurisprudence*
Humans
Risk
Tumor Cells, Cultured*
Viral Vaccines*
Substances
Viral Vaccines